We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$207M
AUM Growth
+$72.1M
Cap. Flow
+$59.3M
Cap. Flow %
28.65%
Top 10 Hldgs %
47.42%
Holding
159
New
12
Increased
64
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$6.79M
2
WPZ
Williams Partners L.P.
WPZ
+$5.53M
3
BPL
Buckeye Partners, L.P.
BPL
+$5M
4
ET icon
Energy Transfer Partners
ET
+$3.75M
5
EPD icon
Enterprise Products Partners
EPD
+$3.26M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$4.42M
2
MDVN
MEDIVATION, INC.
MDVN
+$546K
3
RLYP
RELYPSA INC COM
RLYP
+$521K
4
TRGP icon
Targa Resources
TRGP
+$430K
5
USO icon
United States Oil Fund
USO
+$16K

Sector Composition

Rank Sector Weight
1 Energy 63.86%
2 Healthcare 21.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
51
Enanta Pharmaceuticals
ENTA
$372M
$709K 0.34%
26,649
+3,357
+14% +$78K
UTHR icon
52
United Therapeutics
UTHR
$26.3B
$685K 0.33%
5,804
+731
+14% +$87.8K
REGN icon
53
Regeneron Pharmaceuticals
REGN
$68.8B
$683K 0.33%
1,698
+213
+14% +$85.4K
AMGN icon
54
Amgen
AMGN
$203B
$679K 0.33%
4,071
+514
+14% +$86.9K
PDLI
55
DELISTED
PDL BioPharma, Inc.
PDLI
$666K 0.32%
198,901
+25,064
+14% +$79.6K
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
$644K 0.31%
17,865
– –
MNTA
57
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$644K 0.31%
55,093
+6,942
+14% +$81.6K
MDCO
58
DELISTED
Medicines Co
MDCO
$644K 0.31%
17,070
+2,151
+14% +$81.1K
CELG
59
DELISTED
Celgene Corp
CELG
$644K 0.31%
6,162
+776
+14% +$84K
MACK
60
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$636K 0.31%
12,721
+1,603
+14% +$66.5K
OMER icon
61
Omeros
OMER
$709M
$624K 0.3%
55,936
+7,049
+14% +$80.4K
VRTX icon
62
Vertex Pharmaceuticals
VRTX
$121B
$594K 0.29%
6,814
+859
+14% +$81.2K
GILD icon
63
Gilead Sciences
GILD
$161B
$589K 0.28%
7,450
+939
+14% +$76.3K
ALXN
64
DELISTED
Alexion Pharmaceuticals
ALXN
$581K 0.28%
4,745
+598
+14% +$77K
KERX
65
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$562K 0.27%
105,877
+13,341
+14% +$71.9K
ARNA
66
DELISTED
Arena Pharmaceuticals Inc
ARNA
$556K 0.27%
31,763
+4,002
+14% +$66.4K
LGND icon
67
Ligand Pharmaceuticals
LGND
$6.02B
$549K 0.27%
8,627
+1,085
+14% +$79.7K
CQP icon
68
Cheniere Energy
CQP
$31.8B
$515K 0.25%
17,587
+5,902
+51% +$164K
PBYI icon
69
Puma Biotechnology
PBYI
$406M
$514K 0.25%
7,666
– –
VTAE
70
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$512K 0.25%
24,463
– –
ARRY
71
DELISTED
Array Biopharma Inc
ARRY
$507K 0.25%
75,100
– –
ACAD icon
72
Acadia Pharmaceuticals
ACAD
$4.25B
$505K 0.24%
15,878
+2,001
+14% +$67.8K
ACOR
73
DELISTED
Acorda Therapeutics
ACOR
$505K 0.24%
201
+25
+14% +$74.6K
PTCT icon
74
PTC Therapeutics
PTCT
$6.37B
$488K 0.24%
34,849
– –
GDX icon
75
VanEck Gold Miners ETF
GDX
$23B
$487K 0.24%
+18,431
New +$529K
1 2
3
4 5

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, Virtus ETF Advisers held 159 positions worth $207M, up 53% from $135M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Virtus ETF Advisers deployed $59.3M of net new capital in Q3 2016, opening 12 new positions and adding to 64 existing holdings. Its largest new stake was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, down from 64% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Williams Companies, an estimated $4.42M trimmed.

  • Virtus ETF Advisers's largest Q3 2016 buy was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q3 2016, an estimated $6.79M increase.
  • Virtus ETF Advisers's biggest Q3 2016 reduction was Williams Companies, cutting an estimated $4.42M.
  • Virtus ETF Advisers fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $546K.
  • Virtus ETF Advisers's ten largest holdings make up 47% of its $207M portfolio in Q3 2016.
  • Virtus ETF Advisers opened 12 new positions and closed 5 in Q3 2016.
  • Virtus ETF Advisers's portfolio value rose 53% quarter-over-quarter to $207M.

Based on Virtus ETF Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.